Clinical guidelines and real antimicrobial pharmacotherapy of patients with rhinosinusitis
- Авторлар: Batishcheva G.A1, Vlasenkova A.A1, Goncharova N.Y.1, Cherenkova O.V1
-
Мекемелер:
- Voronezh State Medical University named after N.N. Burdenko
- Шығарылым: № 4S (2022): Supplement
- Беттер: 14-18
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/276970
- DOI: https://doi.org/10.18565/therapy.2022.4suppl.14-18
- ID: 276970
Дәйексөз келтіру
Аннотация
The pharmacotherapy of inflammatory diseases of the parana-sal sinuses of 104 patients was analyzed, which were hospitalized to the otorhinolaryngological department in the period from January 2020 to December 2021. All patients were divided into two groups: group 1 (n=28) - with acute polysinusitis, group 2 (n=76) - with chronic polysinusitis. According to the results of a bacteriological study, 38,2% investigations of the total number were positive in the first group, 75% - in the second group. The main causative agents of sinusitis were S. aureus and S. epidermidis. In both groups, most of the patients received ceftriaxone 2 g/day, which does not take into account the current guidelines for curbing the growth of antibiotic resistance.
Негізгі сөздер
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
G. Batishcheva
Voronezh State Medical University named after N.N. Burdenko
A. Vlasenkova
Voronezh State Medical University named after N.N. Burdenko
N. Goncharova
Voronezh State Medical University named after N.N. Burdenko
O. Cherenkova
Voronezh State Medical University named after N.N. Burdenko
Әдебиет тізімі
- Давидович Н.В., Кукалевская Н.Н., Башилова Е.Н., Бажукова Т.А. Основные принципы эволюции антибиотикорезистентности у бактерий (обзор литературы). Клиническая лабораторная диагностика. 2020; 6: 387-393. doi: 10.18821/0869-2084-2020-65-6-387-393.
- Федорова О.С., Федосенко С.В., Федотова М.М., Чигрина В.П. Антибактериальная терапия и отношение к проблеме антибиотикорезистентности во врачебной практике. Профилактическая медицина. 2021; 10: 106-118. doi: 10.17116/profmed202124101106.
- Акимкин В.Г., Тутельян А.В., Шулакова Н.И., Воронин Е.М. Пандемия COVID-19: новый виток нарастания антибиотикорезистентности. Инфекционные болезни. 2021; 3: 133-138. doi: 10.20953/1729-9225-2021-3-133-138.
- Орлова Ю.Ю., Сперанская Е.М., Никифорова П.Л., Мясникова И.А. Воспалительные заболевания околоносовых пазух в Чувашской республике. Антибактериальная терапия в оториноларингологии. 2019; 96-100.
- Клинические рекомендации. Острый синусит. Национальная медицинская ассоциация оториноларингологов. 2021. Рубрикатор клинических рекомендаций Минздрава России. ID: 313. Доступ: https://cr.minzdrav.gov.ru/schema/313_2 (дата обращения - 04.04.2022).
- Gregory J., Huynh B., Tayler B. et al. High-dose vs standard-dose amoxicillin plus clavulanate for adults with acute sinusitis: A randomized clinical trial. JAMA Netw Open. 2021; 4(3): e212713. doi: 10.1001/jamanetworkopen.2021.2713.
Қосымша файлдар
![](/img/style/loading.gif)